Life Sciences

Marketing Authorization Granted for AbbVie’s Migraine T...

AbbVie, a prominent player in the pharmaceutical industry, has recently achieved...

Bayer Banks on Kerendia’s Potential in Heart Failure Space

Kerendia (finerenone), manufactured by Bayer and approved two summers ago for th...

European Commission Approves Updated Pfizer-BioNTech Va...

The European Commission has recently achieved a significant milestone in the ong...

AmerisourceBergen Sheds Its Decades-Old Identity to Eme...

AmerisourceBergen, the pharmaceutical manufacturing and services firm, has retir...

Bristol Myers Secures Crucial FDA Approval for Treatmen...

In a strategic move to counteract the impending patent challenges for some of it...

Beta Bionics Secures $100 Million for Artificial Pancre...

Beta Bionics, a Massachusetts-based company, has garnered a substantial infusion...

Rite Aid to file for bankruptcy to reorganize debt and ...

Rite Aid is reportedly on the brink of initiating a bankruptcy filing within the...

Novocure’s TTFields Misses the Mark in Phase 3 Ovarian ...

In a striking departure from earlier this year’s promising findings, Novocure’s ...

GE HealthCare introduces Vscan Air SL: a handheld ultra...

GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultr...

BridgeBio Explores Phase 3 Acoramidis Data in Depth

BridgeBio is delving deeper into the phase 3 research of acoramidis, focusing on...

Boston Scientific’s Farapulse System Irregular Heartbea...

Boston Scientific, a pioneering force in medical technology, has revealed clinic...

Self-adjusting spinal cord stimulator from Medtronic re...

While traditional systems for spinal cord stimulation play a significant role in...

Mallinckrodt Inching Closer to Second Bankruptcy Filing

Mallinckrodt has publicly disclosed its imminent initiation of the next phase of...

Roche posts encouraging interim study results for a lun...

Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlig...

FDA Panel’s Divided Verdict Delays Approval for Medtron...

Medtronic’s pursuit of FDA approval for its blood pressure treatment device has ...

Regeneron receives FDA approval for longer-lasting visi...

The recent approvals signal a swifter turnaround for Regeneron than what analyst...